Skip to main content
OpenTrials
Completed

NCT Number: NCT00540215

GLP-2 (Glucagonlike Peptide-2) and Blood Flow

It is the study aim to investigate the effect of glp-2 on blood flow in humans. we wish to study eventual changes in renal blood flow, carotic blood flow and cardiac out put.

GLP-2 will be administered subcutaneously, and the effect monitored by doppler ultra sound scannings and cotinuesly measuring of cardiac out put and blood pressure.

The study will include 15 healhty volunteers, 10 wil receive 450 nmol GLP-2 and 5 will receive 1 ml of isotonic saline (as baseline reference).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Glostrup University Hospital

Glostrup Municipality, Capital Region, 2600, Denmark

About this study

se the above

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 20-60
  • Healthy
  • No medication
  • Not pregnant

Exclusion criteria

  • All of the persons not meeting the abowe mentioned criteria

Treatment and study plan

Glucagonlike peptide

Other

450 nmol native form, synthetic

Primary outcomes

  1. effect of glp-2

    Time frame: during study

Secondary outcomes

  1. potential new ideas for further studies

    Time frame: months to years

Sponsors and collaborators

Lead sponsor

Glostrup University Hospital, Copenhagen

Other

Registry information

Official study title

The Role of GLP-2 in Univercal Changes in Blood Flow in Humans

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Oct 5, 2007
Registry last updated
Feb 11, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.